Skip to main content
. 2020 Apr 8;2020:5419846. doi: 10.1155/2020/5419846

Table 5.

Results of subgroup analysis and interaction analysis.

Characteristic No. OR (95% CI) P for interaction
Age (years) 0.808
 <50 169 1.60 (0.73, 3.53)
 50-60 163 2.01 (1.21, 3.35)
 >60 191 1.63 (1.00, 2.63)
Gender 0.706
 Male 441 1.66 (1.18, 2.33)
 Female 82 2.10 (0.67, 6.57)
BMI (kg/m2) 0.448
 <23 214 1.51 (0.32, 7.12)
 23-26.5 216 3.69 (1.01, 13.40)
 >26.5 215 6.67 (0.91, 48.89)
Smoking 0.039
 No 314 2.36 (1.51, 3.68)
 Yes 209 1.18 (0.72, 1.95)
DM 0.271
 No 498 1.82 (1.31, 2.53)
 Yes 25 0.53 (0.04, 7.96)
Hypertension 0.217
 No 137 1.08 (0.44, 2.70)
 Yes 386 1.90 (1.32, 2.74)
Stroke 0.635
 No 507 1.70 (1.22, 2.35)
 Yes 16 1.37 (0.59, 3.19)
Atherosclerosis 0.749
 No 472 1.70 (1.22, 2.36)
 Yes 51 2.20 (0.49, 9.80)
CRI 0.389
 No 507 1.60 (1.13, 2.27)
 Yes 16 1.22 (0.90, 1.65)
WBC (×109/L) 0.057
 <9 173 1.26 (0.75, 2.10)
 9-12 175 3.33 (1.71, 6.50)
 >12 174 1.54 (0.80, 2.98)
PLT (×109/L) 0.875
 <160 174 1.94 (1.16, 3.25)
 160-210 171 1.59 (0.84, 3.00)
 >210 178 1.91 (1.06, 3.45)
Hb (g/L) 0.406
 <120 168 1.57 (1.05, 2.35)
 120-135 175 1.19 (0.46, 3.08)
 >135 180 2.55 (1.19, 5.43)
ALT (u/L) 0.663
 <15 173 2.17 (1.25, 3.78)
 15-25 172 1.43 (0.68, 3.02)
 >25 173 1.77 (1.01, 3.11)
AST (u/L) 0.571
 <15 171 2.15 (1.16, 3.98)
 15-25 172 1.99 (1.12, 3.54)
 >25 176 1.41 (0.78, 2.54)
Cr (umol/L) 0.801
 <70 172 1.99 (0.69, 5.72)
 70-92 174 1.31 (0.62, 2.76)
 >92 174 1.62 (1.06, 2.46)
UA (mmol/L) 0.618
 <5 173 2.29 (1.08, 4.84)
 5-7 172 1.43 (0.80, 2.54)
 >7 173 1.72 (1.05, 2.83)
Operation 0.020
 No 117 2.73 (1.58, 4.71)
 Yes 406 1.04 (0.52, 2.10)

Abbreviations: CI: confidence interval; OR: odds ratio; BMI: body mass index; WBC: white blood cells count; PLT: platelet count; Hb: hemoglobin; ALT: alanine transaminase; AST: aspartate aminotransferase; Cr: creatinine; UA: uric acid; DM: diabetes mellitus; MFS: Marfan syndrome; CRI: chronic renal insufficiency; TG/HDL-c ratio: triglyceride/high-density lipoprotein cholesterol ratio.